BioSpace News Archive

Policy

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ACRS

Pomerantz LLP announces that a class action lawsuit has been filed against Aclaris Therapeutics Inc. and certain of its officers.

September 26, 2019
·
3 min read
Biotech Bay

Monterey Peninsula Surgery Centers, LLC Named Ambulatory Surgery Center of the Year for a Second Time

Monterey Peninsula Surgery Centers, LLC announced it was honored with two awards at the California Ambulatory Surgery Association’s 2019 Annual Conference.

September 26, 2019
·
2 min read
Deals

Appili Therapeutics Announces Voting Results of Annual and Special Meeting of Shareholders

Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, announced the voting results from its annual and special meeting of shareholders held on Thursday, September 26, 2019.

September 26, 2019
·
3 min read
Drug Development

Samsung Bioepis Announces Phase 3 Results of SB8, Bevacizumab Biosimilar Candidate, at the European Society for Medical Oncology (ESMO) 2019 Congress

Samsung Bioepis Co., Ltd. announced results from the Phase 3 study evaluating the efficacy and safety of SB8, a bevacizumab biosimilar candidate, compared to reference bevacizumab in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC).

September 26, 2019
·
4 min read
FDA

AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes

MAVYRET® (glecaprevir/pibrentasvir) is now available as the only 8-week pan-genotypic treatment option for treatment-naïve chronic hepatitis C (HCV) patients, without cirrhosis or with compensated cirrhosis

September 26, 2019
·
9 min read
Business

CORRECTING and REPLACING Marti Lindsey, PhD, of the University of Arizona, to Be Honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year

The Arizona Bioindustry Association (AZBio) announced that Marti Lindsey, PhD, community engagement director for the Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy and founder and co-director of the KEYS High School Student Internship program at the UA BIO5 Institute, will be honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year at the AZBio Awards on Oct. 2, 2019.

September 26, 2019
·
5 min read
Deals

AMN Healthcare Announces Pricing of Senior Notes Offering - Sept. 26, 2019

AMN Healthcare Services, Inc., announced that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $300 million aggregate principal amount of Senior Notes due 2027.

September 26, 2019
·
3 min read
Policy

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT

Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. and certain of its officers.

September 26, 2019
·
4 min read
BioCrossroads announces DataX BioInnovation Challenge

Competition was developed to encourage intersection of IT with life sciences research on two Hoosier health issues - diabetes and opioid addiction

September 26, 2019
·
3 min read
Biotech Bay

Caribou Biosciences announces that JAMS panel issued Interim Award in the arbitration with Intellia Therapeutics

A three-member JAMS panel issued an Interim Award in the arbitration between Intellia Therapeutics, Inc. and Caribou Biosciences, Inc.

September 26, 2019
·
3 min read